Purchase Order HT942523P0004
Award Date 11/28/22
Potential Completion Date 11/27/25
Potential Value $1.7M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $299,999.66 firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc., a for-profit biotechnology company. The contract is for the development of novel nanotherapeutics to combat viral infections and other biological threats, with a performance period through June 2026. Eitr Biologics has previously received multiple federal contract awards and grants from agencies like the Centers for Disease Control and Prevention (CDC) and the...
- This is a $750,000.00 firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc. for the development of novel nanotherapeutic approaches for the treatment of pneumonic plague. The order is part of a larger $4.39 million Indefinite Delivery Vehicle (IDV) contract between Eitr Biologics and DHA to advance the research and development of nanotherapeutics to combat biological threats. The work will be performed in San Diego, California and involves assessing...
- This is a $315,662,883.70 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Eitr Biologics, Inc. to develop a multimodal antibody platform to extend the window of immunotherapeutic intervention against viral infections. The contract has a performance period through September 2030 and is not a set-aside. Eitr Biologics is a for-profit biotechnology company specializing in antibody-based platforms and antibody discovery...
- The Defense Health Agency awarded a $19,320 firm fixed-price delivery order to Bioivt, LLC for cryoplateable hepatocytes. The contract, awarded on August 11, 2025, with an ultimate completion date of September 30, 2025, represents a non-competitive delivery order issued under an existing indefinite delivery vehicle. Bioivt, headquartered in Westbury, New York, will perform all work at its primary facility location. No set-aside designation was utilized for this procurement, indicating the...
- The U.S. Defense Health Agency, through its Medical Supply Chain division, awarded a $1,767 firm fixed-price purchase order to Biomerieux Inc. (doing business as Vitek Systems, Inc.) on June 4, 2021, for blood collecting equipment. The contract, which was completed by July 6, 2021, will be performed in Eno Valley, North Carolina. This award was not designated as a set-aside contract, reflecting Biomerieux's status as a specialized provider of diagnostic solutions to federal healthcare...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Echelon Biosciences Inc., a small business manufacturer of goods, under the Army SBIR (Small Business Innovation Research) Phase I program. The contract has a potential value of $167,499.96 and a completion date of September 30, 2020. Echelon Biosciences Inc. is a subsidiary of Frontier Scientific, Inc., a for-profit organization that...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- This is a federal contract award to Miltenyi Biotec, Inc., a biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. The award, valued at $4,563.50, is for the acquisition of antibodies from Miltenyi Biotec. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is a firm fixed-price purchase order with no set-aside designation. Miltenyi...
- This is a $3,010,545.01 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Integrum Scientific LLC, a self-certified small disadvantaged business, for blood collection and database creation services. The contract supports the development of monoclonal antibody therapeutics and evaluation of the immune responses in survivors of Marburg Virus disease (MVD) outbreaks in Uganda and Venezuelan Equine Encephalitis (VEE) outbreaks in Panama. The contractor will...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Ebioscience, Inc., a subsidiary of Affymetrix, Inc. The contract, valued at $5,465.50, is for the procurement of drugs and biologicals. The contract does not have a set-aside designation. The award was made on May 21, 2012, with a completion date of June 20, 2012. Ebioscience, Inc. is a for-profit...